LOW-DENSITY LIPOPROTEIN CHOLESTEROL CONTROL AND RATES OF CARDIOVASCULAR EVENTS OVER TIME IN MYOCARDIAL INFARCTION PATIENTS TREATED WITH LIPID-LOWERING THERAPY IN THE UNITED KINGDOM

被引：0
|
作者：
Beaini, Y. [1 ,2 ,3 ]
Danese, M. [4 ]
Sidelnikov, E. [5 ]
Villa, G. [5 ]
Catterick, D. [6 ]
Iqbal, M. [6 ]
Gleeson, M. [4 ]
Lubeck, D. [4 ]
Patel, J. [7 ]
机构：
[1] Bradford & Airedale CCG, Bradford, W Yorkshire, England
[2] West Yorkshire Hlth Care Partnership NHS, Bradford, W Yorkshire, England
[3] Univ Bradford, Bradford, W Yorkshire, England
[4] Outcomes Insights Inc, Agoura Hills, CA USA
[5] Amgen Europe GmbH, Rotkreuz, Switzerland
[6] Amgen Ltd, Uxbridge, Middx, England
[7] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV64
引用
收藏
页码：S498 / S498
页数：1
相关论文
共 50 条
  • [21] Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China
    Wang, Xing
    He, Yan
    Wang, Tao
    Li, Chunming
    Ma, Zihui
    Zhang, Heng
    Ma, Handong
    Zhao, Hongxin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (04) : 307 - 315
  • [22] THE FRIEDEWALD-LEVY-FREDRICKSON FORMULA FOR CALCULATING LOW-DENSITY LIPOPROTEIN CHOLESTEROL, THE BASIS FOR LIPID-LOWERING THERAPY
    ROBERTS, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (04): : 345 - 346
  • [23] Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl
    Aronow, WS
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (05): : 668 - +
  • [24] Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease
    Mendelson, G
    Aronow, WS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : 1128 - 1131
  • [25] Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
    Grundy, SM
    CIRCULATION, 2002, 106 (20) : 2526 - 2529
  • [26] Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
    Feeman, WE
    CIRCULATION, 2003, 107 (20) : E199 - E199
  • [27] Low-Density Lipoprotein Cholesterol Level and Statin Therapy in Patients With Acute Myocardial Infarction (Cholesterol Paradox)
    Nozue, Tsuyoshi
    CIRCULATION JOURNAL, 2016, 80 (02) : 323 - 324
  • [28] Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein
    Backes, JM
    Gibson, CA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (03) : 523 - 526
  • [29] Low-density lipoprotein cholesterol paradox in patients with acute myocardial infarction
    Lee, J. H.
    Chae, S. C.
    Jeong, M. H.
    Kim, Y. J.
    Kim, K. S.
    Hur, S. H.
    Seong, I. W.
    Hong, T. J.
    Cho, M. C.
    Kim, C. J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 34 - 35
  • [30] Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
    Landmesser, Ulf
    Pirillo, Angela
    Farnier, Michel
    Jukema, J. Wouter
    Laufs, Ulrich
    Mach, Francois
    Masana, Luis
    Pedersen, Terje R.
    Schiele, Francois
    Steg, Gabriel
    Tubaro, Marco
    Zaman, Azfar
    Zamorano, Pepe
    Catapano, Alberico L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2020, 42 : E49 - E58
12345